Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_provenance.
- NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_assertion description "[In athymic mice bearing hormone-refractory PC-3 prostate tumor xenografts, intravenous treatment with a liposomal formulation of TNFAIP8 antisense oligonucleotide (LE-AS5) caused reduced expression of TNFAIP8 in tumor tissues, and a combination of LE-AS5 and radiation or docetaxel treatment resulted in significant inhibition of PC-3 tumor growth as compared to single agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_provenance.
- NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_assertion evidence source_evidence_literature NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_provenance.
- NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_assertion SIO_000772 23280553 NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_provenance.
- NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_assertion wasDerivedFrom befree-20140225 NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_provenance.
- NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_assertion wasGeneratedBy ECO_0000203 NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP201582.RAR3V6d_RlokJhku-XZAQVrUZnkPBsQ5LRVPz5lnPSlXs130_provenance.